Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3034% above fair value
$700.22+0.78 (+0.11%)
Close on Nov 13, 2026Market cap $259.44BP/E 37.0Yield 0.25%
Thermo Fisher Scientific cash
Cash and short-term investments held at the end of each period.
Thermo Fisher Scientific's cash was $6.06B at Sep 26, 2026. For fiscal 2025 it was $10.11B, up 80.4% from the year before. Over ten years it grew 36.0% a year on average. The highest annual figure on record is $10.34B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.11B | +80.4% |
| FY2024 | Dec 31, 2024 | $5.60B | -30.9% |
| FY2023 | Dec 31, 2023 | $8.10B | -5.1% |
| FY2022 | Dec 31, 2022 | $8.54B | +90.1% |
| FY2021 | Dec 31, 2021 | $4.49B | -56.5% |
| FY2020 | Dec 31, 2020 | $10.34B | +326.8% |
| FY2019 | Dec 31, 2019 | $2.42B | +14.4% |
| FY2018 | Dec 31, 2018 | $2.12B | +55.5% |
| FY2017 | Dec 31, 2017 | $1.36B | +67.8% |
| FY2016 | Dec 31, 2016 | $811.00M | +74.0% |
| FY2015 | Dec 31, 2015 | $466.00M | -66.0% |
| FY2014 | Dec 31, 2014 | $1.37B | -76.5% |
| FY2013 | Dec 31, 2013 | $5.83B | +619.9% |
| FY2012 | Dec 31, 2012 | $809.90M | -20.6% |
| FY2011 | Dec 31, 2011 | $1.02B | +10.2% |
| FY2010 | Dec 31, 2010 | $926.00M | -41.1% |
| FY2009 | Dec 31, 2009 | $1.57B | +22.0% |
| FY2008 | Dec 31, 2008 | $1.29B | +106.0% |
| FY2007 | Dec 31, 2007 | $625.10M | -6.3% |
| FY2006 | Dec 31, 2006 | $667.40M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $6.06B | +69.5% |
| Q2 FY2026 | Jun 27, 2026 | $4.06B | -36.7% |
| Q1 FY2026 | Mar 28, 2026 | $3.26B | -45.6% |
| Q4 FY2025 | Dec 31, 2025 | $10.11B | +80.4% |
| Q3 FY2025 | Sep 27, 2025 | $3.58B | -46.4% |
| Q2 FY2025 | Jun 28, 2025 | $6.42B | -27.5% |
| Q1 FY2025 | Mar 29, 2025 | $5.99B | -17.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.60B | -30.9% |
| Q3 FY2024 | Sep 28, 2024 | $6.67B | +8.1% |
| Q2 FY2024 | Jun 29, 2024 | $8.85B | +180.6% |
| Q1 FY2024 | Mar 30, 2024 | $7.27B | +107.7% |
| Q4 FY2023 | Dec 31, 2023 | $8.10B | -5.1% |
| Q3 FY2023 | Sep 30, 2023 | $6.17B | +110.2% |
| Q2 FY2023 | Jul 1, 2023 | $3.15B | +65.5% |
| Q1 FY2023 | Apr 1, 2023 | $3.50B | +25.9% |
| Q4 FY2022 | Dec 31, 2022 | $8.54B | +90.1% |
| Q3 FY2022 | Oct 1, 2022 | $2.93B | -75.6% |
| Q2 FY2022 | Jul 2, 2022 | $1.91B | -72.9% |
| Q1 FY2022 | Apr 2, 2022 | $2.78B | -50.4% |
| Q4 FY2021 | Dec 31, 2021 | $4.49B | -56.5% |
| Q3 FY2021 | Oct 2, 2021 | $12.05B | +59.2% |
| Q2 FY2021 | Jul 3, 2021 | $7.04B | +20.5% |
| Q1 FY2021 | Apr 3, 2021 | $5.60B | +86.1% |
| Q4 FY2020 | Dec 31, 2020 | $10.34B | +326.8% |
| Q3 FY2020 | Sep 26, 2020 | $7.57B | +480.1% |
| Q2 FY2020 | Jun 27, 2020 | $5.84B | +152.2% |
| Q1 FY2020 | Mar 28, 2020 | $3.01B | +166.8% |
| Q4 FY2019 | Dec 31, 2019 | $2.42B | +14.4% |
| Q3 FY2019 | Sep 28, 2019 | $1.31B | +17.5% |
| Q2 FY2019 | Jun 29, 2019 | $2.31B | +142.1% |
| Q1 FY2019 | Mar 30, 2019 | $1.13B | +15.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.12B | +55.5% |
| Q3 FY2018 | Sep 29, 2018 | $1.11B | +46.6% |
| Q2 FY2018 | Jun 30, 2018 | $956.00M | +52.0% |
| Q1 FY2018 | Mar 31, 2018 | $975.00M | +32.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.36B | +67.8% |
| Q3 FY2017 | Sep 30, 2017 | $758.00M | – |
| Q2 FY2017 | Jul 1, 2017 | $629.00M | – |
| Q1 FY2017 | Apr 1, 2017 | $737.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $811.00M | – |
See a number that looks wrong?